Equillium (EQ) Other Working Capital Changes (2018 - 2026)
Equillium (EQ) reported Other Working Capital Changes of $192000.0 for Q1 2026, up 163.37% year-over-year from $72902.3 in Q1 2025, and down 40.19% quarter-over-quarter from $321000.0 in Q4 2025.
Equillium (EQ) Other Working Capital Changes (2018 - 2026) Analysis & Trends
Equillium (EQ) has 9 years of Other Working Capital Changes data on file, last reported at $192000.0 in Q1 2026.
- Other Working Capital Changes for Q1 2026 came in at $192000.0, up 163.37% year-over-year; the trailing twelve-month figure through Mar 2026 was -$768000.0 (up 94.38% YoY), and the FY2025 annual result was -$1.3 million, up 91.97% from the prior year.
- Other Working Capital Changes retreated to $192000.0 in Q1 2026 per EQ's latest filing, from $321000.0 in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $8.6 million in Q4 2023 and troughed at -$6.9 million in Q2 2023.
- A 5-year average of -$872705.9 and a median of -$333000.0 in 2022 frame the typical range for Other Working Capital Changes.
- On a YoY basis, Other Working Capital Changes climbed as much as 1319.57% in 2023 and fell as far as 1961.56% in 2023.
- A 5-year view of Other Working Capital Changes shows it stood at $608000.0 in 2022, then surged by 1319.57% to $8.6 million in 2023, then tumbled by 123.95% to -$2.1 million in 2024, then soared by 115.53% to $321000.0 in 2025, then slumped by 40.19% to $192000.0 in 2026.
- Business Quant data shows EQ's Other Working Capital Changes at $192000.0 in Q1 2026, $321000.0 in Q4 2025, and -$8000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Equillium | 293.17 Mn | 232.78 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 192,000.00 |
| Mar 31, 2026 | 192,000.00 |
| Dec 31, 2025 | 321,000.00 |
| Dec 31, 2025 | 321,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Sep 30, 2025 | -8,000.00 |
| Jun 30, 2025 | -1.27 Mn |
| Jun 30, 2025 | -1.27 Mn |
| Mar 31, 2025 | -303,000.00 |
| Mar 31, 2025 | -303,000.00 |
| Dec 31, 2024 | -2.07 Mn |
| Dec 31, 2024 | -2.07 Mn |
| Sep 30, 2024 | -6.36 Mn |
| Sep 30, 2024 | -6.36 Mn |
| Jun 30, 2024 | -4.93 Mn |
| Jun 30, 2024 | -4.93 Mn |
| Mar 31, 2024 | -2.37 Mn |
| Mar 31, 2024 | -2.37 Mn |
| Dec 31, 2023 | 8.63 Mn |
| Dec 31, 2023 | 8.63 Mn |